Incidence of cardiotoxicity after high cumulative dose of anthracyclines in adult patients with advanced soft tissue sarcomas: A systematic review and meta-analysis. Arterial stiffness and aortic ...

Heart failure is a major health concern and is the only manifestation of cardiovascular disease that is actually becoming more prevalent. It is responsible for more than 1 million hospitalizations per ...

A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

Almost half of patients hospitalized for acute heart failure in Europe are readmitted within a year, according to a new study led by researchers at Karolinska Institutet and published in the European ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

Heart Failure showed that despite a decreased diuretic response in patients with acute decompensated heart failure (ADHF), in ...

Cardiovascular diseases remain the leading cause of global mortality, necessitating robust screening programs. Multidisciplinary care teams reduce mortality rates in complex heart failure patients ...

GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data from 21 patients treated ...

The number of deaths attributable to heart disease, particularly acute myocardial infarction and ischemic heart disease, has declined significantly in the United States over the past 50 years or so, ...